The Opioid Crisis Has a Face — and She Deserves Compassionate, Evidence-Based Care
Opioid addiction does not discriminate — but it does affect women in ways that are distinct from men, and it requires treatment that understands those differences. If you are struggling with opioid use — whether prescription pain medication, heroin, fentanyl, or other opioids — you are navigating one of the most powerful chemical dependencies that exists. The grip of opioids on the brain is biological, not a failure of character. And the pathway to recovery, while challenging, is real and achievable.
At IKANN Wellness, we provide comprehensive opioid addiction treatment for women in Fort Lauderdale that integrates evidence-based behavioral therapies, Medication-Assisted Treatment (MAT) coordination, trauma-informed care, and the distinctive clinical focus on women's biology and experience that effective opioid recovery requires. Our women-only environment creates the safety and trust that allow women to do the deep work of lasting recovery.
Opioid use disorder (OUD) is a medical condition characterized by a problematic pattern of opioid use that causes significant impairment or distress. Opioids — a class that includes heroin, fentanyl, oxycodone, hydrocodone, morphine, and methadone — produce powerful pain-relieving and euphoric effects by binding to opioid receptors in the brain and body. With repeated use, the brain adapts to the presence of opioids, reducing its own production of natural endorphins and requiring the drug to maintain normal function. This neuroadaptation is the biological basis of opioid dependence — it is not a choice, and it is not a moral failure.
Women's vulnerability to opioid use disorder has specific dimensions that are both biological and social. Women are prescribed opioid pain medications more frequently than men, are prescribed higher doses, and are prescribed them for longer durations — despite the fact that they develop physical dependence faster and are more sensitive to opioids' pain-relieving and addictive properties at lower doses. Hormonal influences on opioid sensitivity and the reward system mean that women's risk varies across the menstrual cycle, through pregnancy, and during menopause. The postpartum period represents a particularly vulnerable time, when women who have been taking opioids during pregnancy face simultaneous demands of new motherhood, possible infant withdrawal, social judgment, and their own challenging recovery.
The social dimensions of women's opioid use disorder are equally important. Women with OUD are more likely to have experienced intimate partner violence, childhood sexual abuse, and complex trauma than their male counterparts. The opioids that began as pain management — whether for physical pain or the unbearable emotional pain of trauma — become the only reliable source of relief in a life where safer forms of comfort feel unavailable. Understanding this is not to excuse or minimize the devastating consequences of opioid addiction — it is to insist on treating the whole disease, not just the visible part.
Fentanyl has transformed the opioid crisis in South Florida and across the country. Because fentanyl is 50 to 100 times more potent than morphine and is increasingly found in the drug supply outside of pharmaceutical opioids, overdose risk has escalated dramatically. Women who have developed tolerance to opioids are at particular risk when transitioning between opioid sources — including after a period of abstinence when tolerance has dropped. Our admissions process includes thorough risk assessment and safety planning around these realities.
🧑⚕️ Free Confidential Consultation — Take the first step today. Call (786) 504-7626 to speak with a compassionate member of our team — no obligation, no judgment.
The evidence on opioid use disorder treatment is clear: the most effective approaches combine Medication-Assisted Treatment (MAT) with high-quality behavioral therapy and psychosocial support. At IKANN Wellness, our opioid treatment program integrates all three dimensions — medical, psychological, and social — in a women-focused, trauma-informed framework that addresses the whole person as part of our comprehensive addiction treatment program.
IKANN Wellness does not provide on-site MAT prescribing, but we actively coordinate with MAT providers as part of our integrated treatment approach. Buprenorphine/naloxone (Suboxone), methadone, and naltrexone (Vivitrol) are all FDA-approved medications for opioid use disorder with strong evidence bases. MAT significantly reduces opioid cravings and withdrawal symptoms, lowers overdose risk, and improves treatment retention — it is a medically legitimate and evidence-supported component of comprehensive opioid recovery, not a substitute for "real" recovery. We strongly support women accessing MAT as part of their treatment plan and provide clinical programming that complements medication management with the psychological and social dimensions of recovery that medication alone cannot address.
If you are not currently connected with a MAT provider and are interested in pursuing medication-assisted treatment, our admissions team can connect you with local resources. If you are already on Suboxone or methadone, our clinical team is experienced in providing integrated therapeutic programming alongside medication management.
For most women with opioid use disorder, trauma is central to the story — both as a driver of the original use and as an ongoing factor maintaining it. Our trauma-focused clinical approach uses EMDR therapy, trauma-focused CBT, and somatic experiencing to help women process the experiences that opioids have been quieting. Addressing trauma directly in a safe, supported clinical environment is one of the most powerful things we can do to support lasting opioid recovery — and it is only possible when women feel genuinely safe, which is why the women-only environment of IKANN Wellness matters so profoundly.
Opioid recovery requires rebuilding a life — addressing the vocational, relational, practical, and existential dimensions of what addiction has disrupted. Our IOP programming and connections to community resources support women in repairing relationships, accessing housing and employment resources, navigating childcare challenges during treatment, and building the social connections that are themselves a form of medicine in recovery. Isolation is one of the most powerful relapse triggers — and connection is one of the most powerful protective factors.
Active coordination with buprenorphine/naloxone and naltrexone prescribers, with clinical programming that complements and integrates with medical management for comprehensive opioid recovery.
Addressing cognitive distortions, high-risk situations, craving management, and the thought patterns that drive opioid-seeking behaviors through structured, evidence-based sessions.
Processing traumatic memories and the chronic pain — both physical and emotional — that opioids have been managing, allowing genuine neurological healing rather than pharmaceutical suppression.
Strengthening commitment to recovery and resolving ambivalence about MAT or behavioral changes, particularly important in early treatment engagement.
Teaching women to observe opioid cravings as temporary mental events rather than imperatives to act, significantly reducing relapse risk through mindfulness practice.
Developing distress tolerance and emotional regulation skills that replace opioid use as a pain management strategy through holistic, skills-based approaches.
Peer support, shame reduction, and the powerful recovery community available in women's-only therapeutic groups facilitated by licensed clinicians.
Supporting mothers in recovery and addressing the relational impacts of opioid use disorder on children and family systems through individual and family sessions.
5–6 hours daily, five days per week. PHP is recommended for women stepping down from medical detox, those with significant psychiatric co-occurring conditions, or those in early opioid recovery who need intensive daily structure to stabilize. MAT coordination is integrated into PHP for women who are receiving medication-assisted treatment.
3 hours per session, three to five days per week with evening scheduling. IOP provides continued intensive support during the sustained recovery period, which for opioid use disorder typically requires 6–12 months of structured care beyond initial detox and stabilization. Evening IOP allows women to maintain work and family responsibilities while continuing structured treatment.
Opioid use disorder frequently co-occurs with the following conditions, all addressed within our integrated dual diagnosis treatment model:
We accept most major insurance plans for opioid addiction treatment. The Affordable Care Act requires most insurance plans to cover substance use disorder treatment. Call (786) 504-7626 or email office@ikannwellness.com to verify your benefits confidentially. Visit our insurance verification page for more details.
Opioids have taken so much — but they have not taken everything. Your life, your relationships, your future are still reachable. Let us help you find the path back.
Opioids have taken so much — but they have not taken everything. Your life, your relationships, your future are still reachable. Let us help you find the path back.
📞 Phone: (786) 504-7626
📧 Email: office@ikannwellness.com
📍 Address: 2901 Stirling Rd, Suite 203, Fort Lauderdale, FL 33312
🕐 Hours: Monday – Sunday, 9:00 AM – 9:00 PM
This website is currently under development and available for preview purposes only. Services shown may not yet be available.